1. 1238. The Novel Semisynthetic Saponin Adjuvant TQL1055 Enhances the Antibody Response to Pertussis Vaccine with an Improved Tolerability Profile over QS-21. (31st December 2020) Authors: Buzz, Chloe; Ragupathi, Govind; Bennett, Sean R; Livingston, Phil; Farris, Eric; Martin, Tyler Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S638 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. HLA-DR peptide occupancy can be regulated with a wide variety of small molecules. Issue 3 (3rd March 2016) Authors: Blazekovic, Francesca; Odukoya, Dana; Butler, Shanitra N.; Mauro, James A.; Ramsamooj, Michael; Puleo, Erika; Szekeres, Karoly; Dana, Dibyendu; Kumar, Sanjai; Ragupathi, Govind; Blanck, George Journal: Human vaccines & immunotherapeutics Issue: Volume 12:Issue 3(2016) Page Start: 593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer. (April 2011) Authors: Ragupathi, Govind; Gardner, Jeffrey R; Livingston, Philip O; Gin, David Y Journal: Expert review of vaccines Issue: Volume 10:Number 4(2011) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer. (April 2011) Authors: Ragupathi, Govind; Gardner, Jeffrey R; Livingston, Philip O; Gin, David Y Journal: Expert review of vaccines Issue: Volume 10:Number 4(2011) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer. (April 2011) Authors: Ragupathi, Govind; Gardner, Jeffrey R; Livingston, Philip O; Gin, David Y Journal: Expert review of vaccines Issue: Volume 10:Number 4(2011) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Quillaja saponin variants with central glycosidic linkage modifications exhibit distinct conformations and adjuvant activities. Issue 3 (15th January 2016) Authors: Walkowicz, William E.; Fernández-Tejada, Alberto; George, Constantine; Corzana, Francisco; Jiménez-Barbero, Jesús; Ragupathi, Govind; Tan, Derek S.; Gin, David Y. Journal: Chemical science Issue: Volume 7:Issue 3(2016:Mar.) Page Start: 2371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression. Issue 3 (20th January 2021) Authors: Cheung, Irene Y.; Cheung, Nai-Kong V.; Modak, Shakeel; Mauguen, Audrey; Feng, Yi; Basu, Ellen; Roberts, Stephen S.; Ragupathi, Govind; Kushner, Brian H. Journal: Journal of clinical oncology Issue: Volume 39:Issue 3(2021) Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗